药房的数字化转型:拥抱在线平台和化品范式的转变
1Department of Pharmacology, College of Medicine, Qassim University, Buraydah, Saudi Arabia. meman@qu.edu.sa.
Journal of health, population, and nutrition
|May 9, 2024
概括
数字化转型正在彻底改变全球药品行业. 像人工智能和区块链这样的新兴技术正在重塑药房服务,教育和在线平台的兴起.
科学领域:
- 数字健康数字健康
- 药房实践 在药房实践.
- 医疗信息学 医疗信息学
背景情况:
- 药品行业正在经历快速的技术进步.
- 数字化是全球药房运营变革的关键驱动力.
研究的目的:
- 审查数字化对全球药品行业的变革性影响.
- 探索新兴技术在重塑药房服务和教育中的作用.
主要方法:
- 在药房数字化转型的文献综述.
- 对人工智能和区块链等技术进步的分析.
- 在COVID-19大流行期间检查在线药房增长和远程药房/远程医疗.
主要成果:
- 在线药房平台已经出现了显著的增长.
- 在COVID-19大流行期间,远程药房和远程医疗发挥了至关重要的作用.
- 化品市场正在在线药店中扩大.
结论:
- 数字化正在从根本上改变药房服务,教育和市场动态.
- 监管挑战和私营部门的影响是医疗保健技术采用的关键因素.
- 未来的趋势表明,数字药房领域的创新和发展仍在继续.
相关概念视频
Drug Biotransformation: Overview
2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
Drug Administration and Therapy Phases: Overview
451
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
451
Biopharmaceutics and Pharmacokinetics: Overview
2.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.0K
Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K
Drug Control Governance: Regulatory Bodies and Their Impact
157
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
157


